The interaction of ifosfamide and aprepitant in gynecologic malignancies()

• Aprepitant combined with ifosfamide may lead to encephalopathy. • Aprepitant–ifosfamide induced encephalopathy was of short duration in these cases.

Detalles Bibliográficos
Autores principales: Shindorf, Mackenzie L., Manahan, Kelly J., Geisler, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862235/
https://www.ncbi.nlm.nih.gov/pubmed/24371715
http://dx.doi.org/10.1016/j.gynor.2013.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862235/
https://www.ncbi.nlm.nih.gov/pubmed/24371715
http://dx.doi.org/10.1016/j.gynor.2013.06.002

Ejemplares similares